About Aptar
Aptar is a publicly listed company based in Crystal Lake (United States) founded in 1992. Regulatory support, brand differentiation, and prototyping services are provided. The company has 13,500 employees. Aptar has completed 13 acquisitions, including Aptar CSP Technologies, CoheroHealth and FusionPKG. Its website aptar.com draws about 97 thousand monthly visits. Its Indian entity Aptar Pharma India Private Limited reported revenue of ₹502 Cr. Aptar offers products and services including Airless Packaging, Aerosol Systems, and Spray Pumps. Its focus areas include Biopharma Outsourcing and Diversified. Similar companies include MannKind Corp, Avidity Biosciences and Sutro Biopharma; 3 of its 3 listed similar companies have raised funding.
Company details
Aptar was founded in 1992 and is headquartered in Crystal Lake, United States. Operations are centered on the delivery of regulatory support, brand differentiation, and prototyping services within the product development sector. Assistance is extended to clients seeking compliance guidance, unique market positioning, and early-stage model creation. The companys domain, aptar.com, facilitates global outreach, with a focus on practical solutions for industries requiring specialized expertise.
- Indian entity revenue₹502 Cr
FY 2025 · +14% YoY
- Indian entity net profit₹86.85 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹145 Cr
FY 2025 · 29% margin
- Latest Funding Round$475M (USD), Debt – Venture
Dec 2014
- Employee Count13,500
- Investments & AcquisitionsAptar CSP Technologies
& 12 more
Associated legal entities of Aptar
Aptar operates through Aptar Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aptar Pharma India Private Limited CIN U29195MH1999PTC207807 | Active | 05 Jul 1999 | Kalyan, Maharashtra | ₹502 Cr | 320 | 3 | View details |
Products & Services of Aptar
Aptar offers a comprehensive portfolio of products and services, including Airless Packaging, Aerosol Systems, and Spray Pumps.
Provides airless solutions for product protection and preservation.
Delivers aerosol devices for beauty and pharmaceutical applications.
Offers pumps for efficient product dispensing in various markets.
Funding Insights of Aptar
- Total Rounds 1
- Last Round Debt – Venture — $475M
- First Round $475M
(Dec 2014)
All 1 funding rounds of Aptar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2014 | $475M | Debt – Venture | – | – | – |
Board of directors of Aptar Pharma India Private Limited (Aptar)
Aptar Pharma India Private Limited is the primary company behind Aptar. The board of Aptar Pharma India Private Limited currently have 3 directors; the longest-serving is Gael Philippe Dominique Touya, appointed in 2019. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gael Philippe Dominique Touya DIN 08350050 | Director | 11 Feb 2019 | 7 yrs 8 mo | Aptar Pharma India Private Limited |
| Anand Nanjayya Hiremath DIN 09654977 | Director | 28 Jun 2022 | 4 yrs 4 mo | Aptar Pharma India Private Limited |
| Sanjay Digambar Kapote DIN 07529860 | Director | 13 Mar 2023 | 3 yrs 7 mo | Aptar Pharma India Private Limited |
People of Aptar
154 people are tracked at Aptar (76 in leadership, 9 in board & advisors, 69 in team); the tracked headcount is 13,500.
| Name | Role | Group |
|---|---|---|
Stephan B. Tanda | President & CEO | Leadership |
Daniel Ackerman | Senior Vice President, Chief Accounting Officer | Leadership |
Alejandro Quercetti | Latin America Finance Director | Leadership |
Paolo Fia | Operations Director | Leadership |
Magdalena Joanna Kaminska | Director, Marketing, Beauty EMEA | Leadership |
Paula Brunner | Supply Chain Director, B+h NA | Leadership |
Kelly Weeks | Senior Director Global Food Market | Leadership |
Neil Wagner | Vice President Of Global Business Services | Leadership |
Augustin de Tilly | Strategy And M&a, Vice President - Aptar Closures | Leadership |
Mohit Markandey | Head Of Quality | Leadership |
Pierre-Yves Favennec | VP Global Operations At Aptar Pharma - Injectables | Leadership |
| President Aptar India And Head Pharma SEA | Leadership | |
Pascal Sircoulomb | Global Business Development Director | Leadership |
Priyesh Shingadia | CFO - Asia & P&l Leader - Closures, India + SEA | Leadership |
Rocco Soccio | Vice President, Operations Beauty EMEA | Leadership |
Abraham Hernandez | Director Of Operations | Leadership |
Fabien Adam | Innovation Director - Prescription | Leadership |
Vanessa Kanu | EVP, CFO | Leadership |
Marc Prieur | President, Aptar Beauty | Leadership |
Xiangwei Gong | President, Aptar Asia & EVP, Strategic Group Development | Leadership |
134 more people are available in the full profile.
Complete people profiles for Aptar
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Aptar
Aptar is a publicly listed company on the NYSE with ticker symbol ATR in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Apr 1993
- Listed onNYSE: ATR
- Listed entityAptarGroup, Inc.
- Exchange sectorProcess industries
- ISINUS0383361039
- Share price$119.21 (+0.22% on the day) · 2026-10-13
- Market capitalisation$7.58B
- Price to earnings21.5
- EPS (diluted, trailing year)$5.53
- Dividend yield1.61%
- Volume (last session)795,704
Financials of Aptar
Figures of Aptar Pharma India Private Limited, the primary company behind Aptar, for FY 2025. Revenue was ₹502 Cr (+14% year on year). Net profit was ₹86.85 Cr (17% margin). EBITDA was ₹145 Cr (29% margin). Revenue has grown at a compounded annual rate of +17% over three years and +18% over five years.
- ₹502 CrRevenue · FY 2025 · +14% YoY
- ₹86.85 CrNet profit · 17% margin
- ₹145 CrEBITDA · 29% margin
- ₹74.4 LakhPaid-up capital
- 320Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $3.78B | $392.8M | $799.7M |
| 2024 | $3.58B | $374.5M | $776.7M |
| 2023 | $3.49B | $284.5M | $712.3M |
| 2022 | $3.32B | $239.3M | $614.0M |
| 2021 | $3.23B | $244.1M | $622.0M |
Balance sheet, profit and loss, cash flow and ratios of Aptar Pharma India Private Limited are on its company page.
Detailed financial statements for Aptar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptar
Aptar has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Aptar CSP Technologies, CoheroHealth and FusionPKG.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Beverages are distributed on a wholesale basis by Gulf Closures. | 0 | Mar 2023 | •••• | |||
Fragrance products are developed and marketed by iD SCENT. | idscent.net | Bron, France | 2004 | Mar 2023 | •••• | |
Ergonomic, high-touch products are designed and manufactured. | metaphase.com | Saint Louis, United States | 1991 | Sep 2022 | •••• | |
Manufacturer of blood collection tubes & needles | hongyumed.com | Weihai, China | 2001 | Oct 2021 | •••• | |
Remote monitoring platform for chronic disease patients is provided. | voluntis.com | Cambridge, United States | 2001 | Jul 2021 | •••• | |
Enables patients to engage their own care for respiratory illness | coherohealth.com | New York, United States | 2013 | Nov 2020 | •••• | |
Packaging products for the beauty industry are manufactured by FusionPKG. | fusionpkg.com | Dallas, United States | 2004 | Feb 2020 | •••• | |
Provider of drug delivery device training solutions | gonoble.com | Orlando, United States | 1994 | Oct 2019 | •••• | |
Pharmaceutical testing, materials analysis, and forensic services are provided. | gatewayanalytical.com | Gibsonia, United States | 2010 | Jun 2019 | •••• | |
Provider of analytical and product development solutions for orally inhaled and nasal drug products | nanopharm.co.uk | United Kingdom | 2002 | Jun 2019 | •••• |
Complete acquisition details for Aptar
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aptar
13 dated milestones of Aptar across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Aptar is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $475.0M.
- Acquisition Acquires Nanopharm.
- Acquisition Acquires Gateway Analytical.
- Acquisition Acquires GoNoble.
- Acquisition Acquires FusionPKG.
- Acquisition Acquires CoheroHealth.
- Acquisition Acquires Voluntis.
- Acquisition Acquires Weihai Hongyu Medical Devices.
- Acquisition Acquires Metaphase.
- Acquisition Acquires iD SCENT.
- Acquisition Acquires Gulf Closures.
Similar companies to Aptar
Aptar has 3 listed similar companies in our database, 3 of them funded. They include MannKind Corp, Avidity Biosciences and Sutro Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mannkindcorp.com | 1991 | Los Angeles, United States | $50M | 322 | Developer of small-molecule drugs | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed similar companies of Aptar
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aptar
The website of Aptar (aptar.com) receives about 97.2K visits a month and ranks #319,249 among all websites worldwide, #9,299 in Business Services.
- Monthly visits97.2K
▼ 0.8% vs previous month
- Unique visitors41.8K
per month
- Global rank#319,249
among all websites
- Category rank#9,299
Business and Consumer Services · Business Services
- Bounce rate37%
- Pages per visit3.5
- Average visit1 min 30 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Aptar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| visiongain.com | 100% | 5.9K | #3,283,874 | View details | |
parispackagingweek.com | parispackagingweek.com | 96% | #1,026,180 | – | |
| themachinemaker.com | 96% | #1,004,497 | View details | ||
somewang.com | somewang.com | 96% | #543,556 | – | |
| lejournaldesentreprises.com | 96% | #230,202 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Aptar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aptar (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aptar
Complete news archive for Aptar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptar
Aptar was founded in 1992 and raised its 1st funding round 22 years after it was founded.
Aptar is headquartered in Crystal Lake, United States. It is registered at Crystal Lake, Illinois, United States.
Aptar has 13,500 employees.
The primary company behind Aptar, Aptar Pharma India Private Limited, reported revenue of ₹502 Cr for FY 2025, up 14% year on year.
Aptar was founded in 1992 and is headquartered in Crystal Lake, United States. Operations are centered on the delivery of regulatory support, brand differentiation, and prototyping services within the product development sector. Assistance is extended to clients seeking compliance guidance, unique market positioning, and early-stage model creation. The companys domain, aptar.com, facilitates global outreach, with a focus on practical solutions for industries requiring specialized expertise.
Aptar's top competitors include MannKind Corp, Sutro Biopharma and Avidity Biosciences.
Aptar offers Airless Packaging, Aerosol Systems, and Spray Pumps.
Yes, Aptar is publicly traded on NYSE under the ticker symbol ATR.
Aptar has made 13 acquisitions, including Aptar CSP Technologies, CoheroHealth, and FusionPKG.
Aptar operates through Aptar Pharma India Private Limited.
The legal entities of Aptar currently have 3 directors, including Sanjay Digambar Kapote, Anand Nanjayya Hiremath, Gael Philippe Dominique Touya.